Temozolomide
GTM-105
Phase 3 small_molecule active
Quick answer
Temozolomide for Glioblastoma is a Phase 3 program (small_molecule) at GT Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GT Biopharma
- Indication
- Glioblastoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active